Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed May 8, 2017 · 10-Q · 38 days after period end · 0001193125-17-162614
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$3.96M | -$3.33M | -$2.77M | -$2.63M |
| EPS Diluted | -$0.15 | -$0.13 | -$0.13 | -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 8, 2017 · 38 d after period end
